Psychiatry and Neurology, Neurology · Palm Harbor, FL
NPI
1235148743
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
31608 US 19 North
Palm Harbor, FL, 34684
Phone (727) 787-7077
Groups this clinician bills Medicare through
Medicare paid, 2024
$603K
7,451 services
Medicare patients, 2024
751
Average age 75
Drug cost, 2024
$1.9M
5,752 prescriptions
Company payments, 2025
$3,677
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allan M Spiegel was code G0277 (hyperbaric oxygen under pressure, full body chamber, per 30 minute interval), 1,664 times for 14 patients. In total Allan M Spiegel billed 7,451 services in 43 codes, and Medicare paid $603K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0277 Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | Office | 1,664 | 14 | $134.25 | $223K |
| 99214 Office E&M - Established | Office | 1,000 | 557 | $87.32 | $87K |
| 97750 Occupational Therapy | Office | 580 | 570 | $22.62 | $13K |
| 97110 PT Treatment | Office | 489 | 42 | $16.89 | $8,259 |
| 99183 Hyperbaric Oxygen | Office | 416 | 14 | $83.09 | $35K |
| 99204 Office E&M - New | Office | 351 | 351 | $116.72 | $41K |
| 92507 Speech Therapy | Office | 341 | 65 | $53.23 | $18K |
| 97112 PT Treatment | Office | 340 | 54 | $20.20 | $6,867 |
| 99213 Office E&M - Established | Office | 302 | 208 | $66.94 | $20K |
| 97530 PT Treatment | Office | 262 | 37 | $26.92 | $7,054 |
| 97140 PT Treatment | Office | 237 | 32 | $15.77 | $3,738 |
| 96116 Behavioral Health Services | Office | 210 | 197 | $65.52 | $14K |
| 95886 Electrical Nerve Conductivity | Office | 194 | 103 | $70.85 | $14K |
| 95819 Neurologic | Office | 133 | 132 | $330.03 | $44K |
| 96132 Behavioral Health Services | Office | 122 | 121 | $98.62 | $12K |
By year: 2022 $778K for 11,711 services; 2023 $554K for 7,554 services; 2024 $603K for 7,451 services.
Medicare prescription drug claims, 2024
In 2024, the drug Allan M Spiegel prescribed most often to Medicare patients was Memantine Hcl, with 781 prescriptions and refills. In total Allan M Spiegel wrote 5,752 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 781 | 1,907 | 282 | $26K |
| Donepezil Hcl Generic | 703 | 1,702 | 282 | $7,189 |
| Gabapentin Generic | 233 | 549 | 83 | $6,503 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 222 | 497 | 77 | $5,799 |
| Levetiracetam Generic | 178 | 447 | 59 | $9,061 |
| Primidone Generic | 171 | 406 | 57 | $4,640 |
| Qulipta Atogepant | 150 | 215 | 42 | $231K |
| Rivastigmine Rivastigmine Tartrate | 148 | 267 | 45 | $9,589 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 146 | 146 | 24 | $3,930 |
| Topiramate Generic | 146 | 317 | 56 | $3,733 |
| Ropinirole Hcl Generic | 135 | 275 | 35 | $5,668 |
| Oxcarbazepine Generic | 123 | 258 | 38 | $10K |
| Duloxetine Hcl Generic | 121 | 290 | 50 | $2,333 |
| Alprazolam Generic | 119 | 140 | 40 | $529 |
| Diclofenac Sodium Generic | 96 | 112 | 56 | $494 |
Brand drugs: 660 claims; generic drugs: 5,073 claims; opioid claims: 293.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Allan M Spiegel $3,677 ($3,677 in general payments such as food, travel and fees) from 27 companies. The largest payer was Lundbeck LLC with $398.
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 21 | $398 |
| UCB, Inc. UCB.BR | 17 | $381 |
| Abbvie Inc. ABBV | 19 | $319 |
| Pfizer Inc. PFE | 16 | $308 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 16 | $308 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $254 |
| Alexion Pharmaceuticals, Inc. AZN | 8 | $224 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $222 |
| SK Life Science, Inc. | 4 | $191 |
| Celgene Corporation BMY | 5 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.